curcumin-ND (Abionyx)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug Namecurcumin-ND (Abionyx)
Drug Alias Namecurcumin-ND (Cerenis Therapeutics)curcumin-ND (Lypro)curcumin-NanoDisks (Lypro)curcumin-NanoDisks (Cerenis Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApoptosis stimulants
TargetsUpdating
Therapy Area/IndicationsLymphoma, Mantle-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLypro Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLypro Biosciences IncAbionyx Pharma SA
Active IndicationsN/A
Inactive IndicationsLymphoma, Mantle-Cell

Other Information

ATC CodeN/A
Related LinksN/A